drugset / Trial / NCT07413744
The Gut - PRO Study
Phase 2
Not yet recruiting
40 enrolled
University of Wisconsin, Madison
International Flavors & Fragrances Inc. · collabNational Institute on Aging (NIA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.
Timeline
- Start
- 2026-08
- Primary completion
- 2029-03
- Completion
- 2029-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VSL#3 | Other / unclassified | — | Oral |